Centogene N.V. (CNTG:NASDAQ) jumped higher at $1.18, representing a gain of 50.8%. On Tue, Jun 27, 2023, CNTG:NASDAQ hit a New 2-Week High of $1.18. The stock got featured on our News Catalysts scanner on Tue, Jun 27, 2023 at 07:55 AM in the 'PATNERSHIP' category. From Tue, Jun 13, 2023, the stock recorded 55.56% Up Days and 40.00% Green Days
The stock spiked on Tue, Apr 25, 2023 at $2.52 with a volume of 43M+.
About Centogene N.V. (CNTG:NASDAQ)
Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It's pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients.
Top 10 Gainers:
- Black Diamond Therapeutics, Inc. (BDTX:NASDAQ), 235.87%
- AC Immune SA (ACIU:NASDAQ), 71.72%
- Leafly Holdings Inc. (LFLY:NASDAQ), 54.81%
- Centogene N.V. (CNTG:NASDAQ), 50.82%
- Tivic Health Systems Inc. (TIVC:NASDAQ), 38.96%
- Ryvyl Inc Com (New) (RVYL:NASDAQ), 36.29%
- CalciMedica Inc Com (New) (CALC:NASDAQ), 33.13%
- VivoPower International PLC (VVPR:NASDAQ), 32.35%
- Statera Biopharma Inc. (STAB:NASDAQ), 25.46%
- Enovix Corporation (ENVX:NASDAQ), 25.23%